CNS Pharmaceuticals, Inc. — DEF 14A Filings
7 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by CNS Pharmaceuticals, Inc. (CNSP), sorted by most recent first. Each row links to the full filing on EdgarLookup. CNS Pharmaceuticals, Inc. has filed 7 DEF 14A documents with the SEC since 2018. To view all SEC filings by CNS Pharmaceuticals, Inc., see the full filings list.
All
1-A
1-A-W
1-A/A
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
C
C-AR
C-TR
C-U
CERT
CORRESP
DEF 14A
DEFA14A
DEFR14A
DOS
DRS
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001683168-25-007760 | Oct 24, 2025 | Nov 17, 2025 |
| DEF 14A | FORM DEF 14A | 0001683168-24-007416 | Oct 28, 2024 | Nov 26, 2024 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-24-002244 | Apr 10, 2024 | Apr 30, 2024 |
| DEF 14A | DEFINITIVE PROXY | 0001683168-23-005773 | Aug 14, 2023 | Sep 14, 2023 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-22-004817 | Jul 7, 2022 | Jul 27, 2022 |
| DEF 14A | DEFINITIVE PROXY | 0001683168-21-002410 | Jun 8, 2021 | Jun 28, 2021 |
| DEF 14A | DEFINITIVE PROXY | 0001683168-20-001282 | Apr 24, 2020 | May 7, 2020 |